Limpet_Chicken
Bluelighter
The opioid is not a 1,4-diacylpiperazine. Its an acyl amide/alkylated derivative, N-1-(n)-butryl-N4-(trans)-cinnamylpiperazine
Was thinking both of making the butyryl analog of sunifiram and testing for activity, as well as preparing the N1-propionyl homolog of the opioid, as well as each of the original compounds.
It'd just be an interesting and handy way to leverage common intermediates, I'm always up for a twoferl so to speak, if some intermediate planned for one project can be leveraged to make two or three more, then why in the hell not. Start out making an AMPAkine, and a one or two-step adaptation to get an opioid and an analog of the opioid out of the intermediate, given the dirt-cheap price for a simple heterocycle like piperazine, then why in the hells not? (already a chronic pain patient, so physical dependence isn't a worry, thats a horse that has already bolted, I have no need to worry whether or not the stable door gets left open. Horse buggered off years ago.)
Was thinking both of making the butyryl analog of sunifiram and testing for activity, as well as preparing the N1-propionyl homolog of the opioid, as well as each of the original compounds.
It'd just be an interesting and handy way to leverage common intermediates, I'm always up for a twoferl so to speak, if some intermediate planned for one project can be leveraged to make two or three more, then why in the hell not. Start out making an AMPAkine, and a one or two-step adaptation to get an opioid and an analog of the opioid out of the intermediate, given the dirt-cheap price for a simple heterocycle like piperazine, then why in the hells not? (already a chronic pain patient, so physical dependence isn't a worry, thats a horse that has already bolted, I have no need to worry whether or not the stable door gets left open. Horse buggered off years ago.)